Controversies in Drug Allergy: Radiographic Contrast Media.
Anaphylaxis
/ etiology
Basophil Degranulation Test
Consensus Development Conferences as Topic
Contrast Media
/ adverse effects
Diagnostic Imaging
/ adverse effects
Drug Hypersensitivity
/ complications
Expert Testimony
Humans
Hypersensitivity, Delayed
Hypersensitivity, Immediate
Skin Tests
United States
Anaphylaxis
Drug allergy
Premedication
RCM
Radiographic contrast media
Skin testing
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
27
06
2018
accepted:
27
06
2018
pubmed:
24
12
2018
medline:
6
5
2020
entrez:
22
12
2018
Statut:
ppublish
Résumé
The risk for developing immediate or delayed hypersensitivity reactions to radiocontrast media (RCM) interferes with the diagnosis and treatment of a number of patients requiring imaging diagnostic methods for many common diseases. A group of experts met in Orlando, Florida, in March 2018 to analyze the similarities and differences in the management of RCM reactions in different areas of the world. This paper presents a summary of the recommendations provided by this consensus group, highlighting controversial issues and unmet needs that require further research.
Identifiants
pubmed: 30573421
pii: S2213-2198(18)30467-7
doi: 10.1016/j.jaip.2018.06.030
pii:
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
61-65Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.